BOLD
Audentes Therapeutics, Inc
BOLD
BOLD
Delisted
BOLD was delisted on the 14th of January, 2020.
139 hedge funds and large institutions have $1.71B invested in Audentes Therapeutics, Inc in 2019 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 49 increasing their positions, 41 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
20% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 41
10% more funds holding
Funds holding: 126 → 139 (+13)
Holders
139
Holding in Top 10
8
Calls
$3.87M
Puts
$1.18M
Top Buyers
| 1 | +$57M | |
| 2 | +$31.4M | |
| 3 | +$23.4M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$16.9M |
| 5 |
Jennison Associates
New York
|
+$12.6M |
Top Sellers
| 1 | -$38.7M | |
| 2 | -$27.9M | |
| 3 | -$20M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$20M |
| 5 |
Morgan Stanley
New York
|
-$17.7M |